| regulation of body fluid levels | GO:0050878 | 162 | 0.430 | |
| forebrain development | GO:0030900 | 302 | 0.331 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.331 | |
| skeletal system development | GO:0001501 | 356 | 0.321 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.318 | |
| muscle system process | GO:0003012 | 141 | 0.277 | |
| fat cell differentiation | GO:0045444 | 160 | 0.277 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.260 | |
| amine metabolic process | GO:0009308 | 45 | 0.241 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.238 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.232 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.224 | |
| regulation of ion transport | GO:0043269 | 215 | 0.223 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.220 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.219 | |
| sodium ion transport | GO:0006814 | 73 | 0.214 | |
| renal inner medulla development | GO:0072053 | 3 | 0.206 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.203 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.203 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.202 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.201 | |
| cartilage development | GO:0051216 | 140 | 0.195 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.190 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.181 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.174 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.167 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.167 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.165 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.165 | |
| organ growth | GO:0035265 | 117 | 0.162 | |
| gastrin induced gastric acid secretion | GO:0001698 | 1 | 0.160 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.155 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.154 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.153 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.149 | |
| renal vesicle induction | GO:0072034 | 3 | 0.147 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.139 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.135 | |
| transmembrane transport | GO:0055085 | 412 | 0.132 | |
| cation transport | GO:0006812 | 399 | 0.132 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.132 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.131 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.127 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.125 | |
| cation homeostasis | GO:0055080 | 212 | 0.122 | |
| spemann organizer formation | GO:0060061 | 2 | 0.122 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.120 | |
| ossification | GO:0001503 | 216 | 0.120 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.119 | |
| cervix development | GO:0060067 | 2 | 0.119 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.118 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.117 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.117 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.116 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.116 | |
| interleukin 8 production | GO:0032637 | 4 | 0.114 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.114 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.113 | |
| regulation of secretion | GO:0051046 | 274 | 0.112 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.106 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.104 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.104 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.102 | |
| circulatory system process | GO:0003013 | 197 | 0.101 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.101 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.101 | |
| gland development | GO:0048732 | 330 | 0.101 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.100 | |
| response to nutrient levels | GO:0031667 | 109 | 0.100 | |
| cerebellum formation | GO:0021588 | 1 | 0.100 | |
| nephric duct formation | GO:0072179 | 4 | 0.100 | |
| inflammatory response | GO:0006954 | 244 | 0.098 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.096 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.096 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.095 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.094 | |
| digestion | GO:0007586 | 40 | 0.093 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.090 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.090 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.088 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.087 | |
| regulation of anagen | GO:0051884 | 1 | 0.084 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.084 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.083 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.083 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.082 | |
| regulation of saliva secretion | GO:0046877 | 2 | 0.082 | |
| heart morphogenesis | GO:0003007 | 178 | 0.082 | |
| metanephric collecting duct development | GO:0072205 | 7 | 0.082 | |
| membrane depolarization | GO:0051899 | 64 | 0.082 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.081 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.081 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.080 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.080 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.080 | |
| epithelial cell development | GO:0002064 | 159 | 0.079 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.079 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.079 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.079 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.078 | |
| stem cell development | GO:0048864 | 219 | 0.078 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.077 | |
| cytokine production | GO:0001816 | 319 | 0.077 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.076 | |
| bone mineralization | GO:0030282 | 54 | 0.076 | |
| lung induction | GO:0060492 | 3 | 0.076 | |
| muscle contraction | GO:0006936 | 101 | 0.075 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.075 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.075 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.074 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.074 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.074 | |
| digestive tract development | GO:0048565 | 190 | 0.073 | |
| vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure | GO:0002025 | 3 | 0.073 | |
| striated muscle contraction | GO:0006941 | 45 | 0.073 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.072 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.072 | |
| cellular homeostasis | GO:0019725 | 240 | 0.072 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.072 | |
| prostate gland epithelium morphogenesis | GO:0060740 | 31 | 0.070 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.070 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.070 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.069 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.069 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.068 | |
| bone development | GO:0060348 | 120 | 0.068 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.068 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.067 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.067 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.066 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.066 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.066 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.065 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.065 | |
| hair cycle phase | GO:0044851 | 16 | 0.064 | |
| connective tissue development | GO:0061448 | 179 | 0.063 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.063 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.063 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.063 | |
| neuroepithelial cell differentiation | GO:0060563 | 37 | 0.062 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.062 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.062 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.061 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.061 | |
| interleukin 1 beta secretion | GO:0050702 | 16 | 0.061 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.061 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.060 | |
| skin development | GO:0043588 | 220 | 0.060 | |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 | 0.060 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.060 | |
| sensory perception | GO:0007600 | 245 | 0.060 | |
| limb development | GO:0060173 | 166 | 0.060 | |
| steroid metabolic process | GO:0008202 | 119 | 0.059 | |
| protein secretion | GO:0009306 | 111 | 0.059 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.059 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.058 | |
| appendage development | GO:0048736 | 166 | 0.058 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.058 | |
| cellular response to lipid | GO:0071396 | 145 | 0.058 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.058 | |
| response to growth factor | GO:0070848 | 198 | 0.057 | |
| biomineral tissue development | GO:0031214 | 64 | 0.057 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.056 | |
| body fluid secretion | GO:0007589 | 53 | 0.056 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.056 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.056 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.056 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.055 | |
| cell cell junction organization | GO:0045216 | 72 | 0.055 | |
| spermatogenesis | GO:0007283 | 284 | 0.055 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.055 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.055 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.054 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.054 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.054 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.054 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.054 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.054 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.054 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.054 | |
| cell adhesion | GO:0007155 | 329 | 0.054 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.054 | |
| cardiac chamber development | GO:0003205 | 108 | 0.054 | |
| liver development | GO:0001889 | 66 | 0.053 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.053 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.053 | |
| artery development | GO:0060840 | 53 | 0.053 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.053 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.052 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.052 | |
| gas homeostasis | GO:0033483 | 3 | 0.052 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.052 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.052 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.051 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.051 | |
| regulation of systemic arterial blood pressure by norepinephrine epinephrine | GO:0001993 | 8 | 0.051 | |
| prostate gland morphogenesis | GO:0060512 | 32 | 0.051 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.051 | |
| lung field specification | GO:0060424 | 3 | 0.051 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.051 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.051 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.051 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.050 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.050 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.050 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.050 | |
| respiratory tube development | GO:0030323 | 167 | 0.050 | |
| stem cell differentiation | GO:0048863 | 268 | 0.049 | |
| kidney epithelium development | GO:0072073 | 121 | 0.049 | |
| regulation of system process | GO:0044057 | 200 | 0.049 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.049 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.048 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.048 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.048 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.047 | |
| heart growth | GO:0060419 | 45 | 0.047 | |
| synapse organization | GO:0050808 | 125 | 0.047 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.047 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.047 | |
| regulation of interleukin 1 production | GO:0032652 | 26 | 0.047 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.047 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.046 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.046 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.046 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.046 | |
| cellular response to parathyroid hormone stimulus | GO:0071374 | 2 | 0.045 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.045 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.045 | |
| lung development | GO:0030324 | 164 | 0.045 | |
| digestive system development | GO:0055123 | 200 | 0.045 | |
| hair cycle | GO:0042633 | 90 | 0.045 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.045 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.045 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.045 | |
| regulation of ossification | GO:0030278 | 112 | 0.044 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.044 | |
| regulation of cell migration | GO:0030334 | 219 | 0.044 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.044 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.043 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.043 | |
| ribosomal small subunit assembly | GO:0000028 | 1 | 0.043 | |
| mesenchyme development | GO:0060485 | 152 | 0.043 | |
| somatostatin signaling pathway | GO:0038170 | 2 | 0.043 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.043 | |
| cell junction organization | GO:0034330 | 77 | 0.043 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.043 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.042 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.042 | |
| amide transport | GO:0042886 | 138 | 0.042 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.042 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.041 | |
| synaptic transmission | GO:0007268 | 329 | 0.041 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.041 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.041 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.041 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.041 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.041 | |
| cell cell adhesion mediated by cadherin | GO:0044331 | 5 | 0.041 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.041 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.041 | |
| bone morphogenesis | GO:0060349 | 78 | 0.041 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.041 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.041 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.041 | |
| hair follicle development | GO:0001942 | 85 | 0.040 | |
| prostate gland development | GO:0030850 | 48 | 0.040 | |
| phospholipase c activating serotonin receptor signaling pathway | GO:0007208 | 1 | 0.040 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.040 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.040 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.040 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.040 | |
| interleukin 1 secretion | GO:0050701 | 16 | 0.040 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.040 | |
| urogenital system development | GO:0001655 | 261 | 0.040 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.040 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.040 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.040 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.040 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.040 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.040 | |
| histamine induced gastric acid secretion | GO:0001697 | 1 | 0.039 | |
| cell division | GO:0051301 | 120 | 0.039 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.039 | |
| stem cell maintenance | GO:0019827 | 130 | 0.039 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.039 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.039 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.039 | |
| midgut development | GO:0007494 | 4 | 0.039 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.039 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.039 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.038 | |
| negative regulation of blood pressure | GO:0045776 | 22 | 0.038 | |
| tissue remodeling | GO:0048771 | 102 | 0.038 | |
| calcium ion transport | GO:0006816 | 159 | 0.038 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.038 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.038 | |
| odontogenesis | GO:0042476 | 78 | 0.037 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.037 | |
| negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072040 | 4 | 0.037 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.037 | |
| tissue regeneration | GO:0042246 | 22 | 0.037 | |
| skin morphogenesis | GO:0043589 | 38 | 0.037 | |
| renal outer medulla development | GO:0072054 | 2 | 0.037 | |
| maintenance of cell number | GO:0098727 | 3 | 0.037 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.037 | |
| memory | GO:0007613 | 58 | 0.036 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.036 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.036 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.036 | |
| gastrulation | GO:0007369 | 116 | 0.036 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.036 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.036 | |
| jnk cascade | GO:0007254 | 72 | 0.036 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.036 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.036 | |
| regulation of cell activation | GO:0050865 | 289 | 0.036 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.035 | |
| action potential | GO:0001508 | 78 | 0.035 | |
| neuronal action potential | GO:0019228 | 54 | 0.035 | |
| angiogenesis | GO:0001525 | 201 | 0.035 | |
| telencephalon development | GO:0021537 | 186 | 0.035 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.035 | |
| ear development | GO:0043583 | 200 | 0.035 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.035 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.034 | |
| sensory perception of taste | GO:0050909 | 18 | 0.034 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.034 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.034 | |
| regulation of interleukin 1 beta production | GO:0032651 | 25 | 0.034 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.034 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.034 | |
| establishment of blood brain barrier | GO:0060856 | 8 | 0.034 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.034 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.034 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.034 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.033 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.033 | |
| regulation of excitatory postsynaptic membrane potential | GO:0060079 | 41 | 0.033 | |
| renal sodium excretion | GO:0035812 | 3 | 0.033 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.033 | |
| tissue homeostasis | GO:0001894 | 115 | 0.033 | |
| sensitization | GO:0046960 | 2 | 0.033 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.033 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.033 | |
| camera type eye development | GO:0043010 | 266 | 0.033 | |
| positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0072108 | 3 | 0.033 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.033 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.033 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.033 | |
| response to hypoxia | GO:0001666 | 58 | 0.033 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.032 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.032 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.032 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.032 | |
| metanephric nephron tubule formation | GO:0072289 | 4 | 0.032 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.032 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.032 | |
| bone trabecula formation | GO:0060346 | 9 | 0.031 | |
| foregut regionalization | GO:0060423 | 3 | 0.031 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 31 | 0.031 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.031 | |
| kidney development | GO:0001822 | 213 | 0.031 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.031 | |
| mapk cascade | GO:0000165 | 281 | 0.031 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.031 | |
| learning | GO:0007612 | 98 | 0.031 | |
| blood circulation | GO:0008015 | 195 | 0.031 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.031 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.031 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.031 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.031 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.031 | |
| axial mesoderm formation | GO:0048320 | 3 | 0.031 | |
| nephron development | GO:0072006 | 109 | 0.031 | |
| response to drug | GO:0042493 | 75 | 0.030 | |
| renal system development | GO:0072001 | 225 | 0.030 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.030 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.030 | |
| interferon gamma production | GO:0032609 | 67 | 0.030 | |
| response to parathyroid hormone | GO:0071107 | 3 | 0.030 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.030 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.030 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.030 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.030 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.030 | |
| endothelial cell development | GO:0001885 | 20 | 0.030 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.030 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.030 | |
| negative regulation of growth | GO:0045926 | 99 | 0.030 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.029 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.029 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.029 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.029 | |
| negative regulation of fibroblast growth factor production | GO:0090272 | 2 | 0.029 | |
| apoptotic process involved in development | GO:1902742 | 28 | 0.029 | |
| mesoderm formation | GO:0001707 | 62 | 0.029 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.028 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.028 | |
| response to metal ion | GO:0010038 | 47 | 0.028 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.028 | |
| stem cell proliferation | GO:0072089 | 117 | 0.028 | |
| cell cell junction assembly | GO:0007043 | 27 | 0.028 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.028 | |
| response to radiation | GO:0009314 | 165 | 0.028 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.028 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.028 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.028 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.028 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.028 | |
| endothelium development | GO:0003158 | 45 | 0.028 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.027 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.027 | |
| specification of organ identity | GO:0010092 | 30 | 0.027 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.027 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.027 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.027 | |
| camp metabolic process | GO:0046058 | 40 | 0.027 | |
| response to light stimulus | GO:0009416 | 135 | 0.027 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.027 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 49 | 0.027 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.027 | |
| cell fate commitment | GO:0045165 | 210 | 0.027 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.027 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.027 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.027 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.026 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.026 | |
| positive regulation of the force of heart contraction by chemical signal | GO:0003099 | 3 | 0.026 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.026 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.026 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.026 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.026 | |
| gtp metabolic process | GO:0046039 | 144 | 0.026 | |
| pallium development | GO:0021543 | 120 | 0.026 | |
| cellular response to temperature stimulus | GO:0071502 | 2 | 0.026 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.026 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.026 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.026 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.025 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.025 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.025 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.025 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.025 | |
| regulation of protein localization | GO:0032880 | 231 | 0.025 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.025 | |
| cytokine secretion | GO:0050663 | 72 | 0.025 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.025 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.025 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.025 | |
| mesonephric tubule formation | GO:0072172 | 11 | 0.025 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.025 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.024 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.024 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.024 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.024 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.024 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.024 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.024 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.024 | |
| operant conditioning | GO:0035106 | 2 | 0.024 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.024 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.024 | |
| regulation of protein transport | GO:0051223 | 163 | 0.024 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.024 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.024 | |
| positive regulation of transcription initiation from rna polymerase ii promoter | GO:0060261 | 5 | 0.023 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.023 | |
| palate development | GO:0060021 | 76 | 0.023 | |
| negative regulation of serotonin secretion | GO:0014063 | 2 | 0.023 | |
| protein kinase c activating g protein coupled receptor signaling pathway | GO:0007205 | 4 | 0.023 | |
| hormone metabolic process | GO:0042445 | 86 | 0.023 | |
| regulation of cell motility | GO:2000145 | 236 | 0.023 | |
| somatostatin receptor signaling pathway | GO:0038169 | 2 | 0.023 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.023 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.023 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.023 | |
| heart induction | GO:0003129 | 2 | 0.023 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.023 | |
| habituation | GO:0046959 | 3 | 0.023 | |
| multicellular organism growth | GO:0035264 | 161 | 0.023 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.023 | |
| positive regulation of actin filament bundle assembly | GO:0032233 | 11 | 0.022 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.022 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.022 | |
| positive regulation of hair follicle development | GO:0051798 | 6 | 0.022 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.022 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.022 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.022 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.022 | |
